Filing Details

Accession Number:
0001181431-10-041134
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-10 13:00:00
Reporting Period:
2010-08-06
Filing Date:
2010-08-10
Accepted Time:
2010-08-10 14:07:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356857 Trius Therapeutics Inc TSRX Pharmaceutical Preparations (2834) 201320630
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1024008 S David Kabakoff C/O Trius Therapeutics, Inc.
6310 Nancy Ridge Drive, Suite 101
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-08-06 5,285 $0.00 5,285 No 4 C Indirect See Footnote
Common Stock Acquisiton 2010-08-06 4,570 $0.00 4,570 No 4 C Indirect By Trust
Common Stock Acquisiton 2010-08-06 30,000 $5.00 34,570 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect By Trust
No 4 P Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A-1 Convertible Preferred Stock Disposition 2010-08-06 45,454 $0.00 45,454 $0.00
Common Stock Series A-1 Convertible Preferred Stock Disposition 2010-08-06 14,304 $0.00 14,304 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2010-08-06 25,000 $0.00 25,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 41,860 Direct
Footnotes
  1. Upon the closing of the Issuer's initial public offering, each 8.6 shares of the Series A-1 Convertible Preferred Stock and Series B Convertible Preferred Stock automatically converted into one share of Common Stock, and had no expiration date.
  2. By Strategy Advisors, LLC Defined Benefit Plan, of which the reporting person has sole voting and investment power.
  3. By The David S. & Susan O. Kabakoff Family Trust dated 2/24/00.